Best of ASCO 2023, Portland

Portland, OR US
June 24, 2023 to June 25, 2023

This CME-accredited oncology conference, Best of ASCO 2023, Portland, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.

Expert faculty will provide a comprehensive overview of practice-changing abstracts presented at the 2023 ASCO® Annual Meeting (ASCO2023) in June 2023. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will place abstract findings from ASCO2023 into clinical contexts and discuss how the results may change the current standard of care.

Target Audience

  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

 

Hotel Information

Book your rooms using the following link:

www.hilton.com/en/book/reservation/             

Learning Objectives

At the conclusion of the activity, participants will be able to:

  1. Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
  2. Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
  3. Explain how to effectively manage side-effects associated with cancer treatment
  4. Review abstracts presented at ASCO® 2023 and discuss their application in clinical settings
Course summary
Available credit: 
  • 11.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 11.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 11.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.00 Contact Hours.
Course opens: 
01/23/2023
Course expires: 
10/16/2023
Event starts: 
06/24/2023 - 8:00am PDT
Event ends: 
06/25/2023 - 12:00pm PDT
Cost:
$350.00

Conference chair: Dr. Julie Graff

DAY 1


All times below are listed in Pacific Standard Time (PST).

07:00 – 08:00 AM: REGISTRATION


08:00 AM – 09:30 AM: HEMATOLOGIC MALIGNANCIES SESSION
Moderator: Curtis Lachowiez, MD

08:00 - 08:30 AM: MDS/leukemias- Jennifer Saultz, DO

08:30 - 09:00 AM: Multiple myeloma- Eva Medvedova, MD

09:00 - 09:30 AM: Lymphoma & CLL- Craig Okada, MD


09:30 – 10:00 AM: BREAK


10:00 – 11:00 AM: THORACIC ONCOLOGY SESSION
Moderator: Andrea Veatch MD

10:00 - 10:30 AM: Early-stage lung cancer- Jeremy Cetnar, MD., MSHPR.

10:30 - 11:00 AM: Metastatic lung cancer- Smitha Menon, MD


11:00 - 12:00 PM: Case-based presentation- Bo Wang, MD, Xiaowen (Wendy) Wang, MD


12:00 – 13:00 PM: LUNCH

12:15 PM to 1:00 PM - Sponsored Product Theater Presented by Menarini Stemline Therapeutics in Three Sisters room.

ORSERDU (elacestrant): The first and only therapy indicated for ER+/HER2- ESR1-mutated mBC following at least one line of endocrine therapy 

Speaker: Rena Callahan MD, Asst Clinical Professor at David Geffen School of Medicine, UCLA

This industry-sponsored program does not provide CME credits.


13:00 – 15:00 PM: GENERAL ONCOLOGY SESSION
Moderator: Peter Jiang, MD

13:00 - 13:30 PM: Sarcoma updates- Michael Wagner, MD

13:30 - 14:00 PM: Brain tumor updates- Prakash Ambady, MD

14:00 - 14:30 PM: Head neck cancer- Hyunseok Kang, MD

14:30 - 15:00 PM: Gynecologic cancer- Dan Veljovich, MD


15:00 – 15:30 PM: BREAK


15:30 – 17:00 PM: GENITOURINARY CANCER SESSION
Moderator: Marshall Strother, MD

15:30 - 16:00 PM: Prostate cancer- Julie Graff, MD

16:00 - 16:30 PM: Bladder cancer- Sudhir Isharwal, MD

16:30 - 17:00 PM: Kidney cancer- Brendan Curti, MD


DAY 2

07:00 – 08:00 AM: REGISTRATION AND BREAKFAST


08:00 – 09:00 AM: SKIN CANCER
Moderator: Elizabeth Berry, MD

08:00 - 08:30 AM: Melanoma update- Cristian D. Valenzuela, MD


08:30 - 09:00 AM: Case-based presentation - Elizabeth Berry, MD, Peter Jiang, MD


09:00 - 10:30 AM: GI CANCER SESSION
Moderator: Andrew Coveler, MD

09:00 - 09:30 AM: Colorectal cancer- Adel Kardosh, MD, PhD

09:30 - 10:00 AM: Hepatobiliary and pancreatic malignancies- Daneng Li, MD

10:00 - 10:30 AM: Upper GI cancer- Emerson Chen, MD


10:30 - 10:45 AM: BREAK


10:45 - 12:15 PM: BREAST CANCER SESSION
Moderator: Fengting Yan, MD, FACP

10:45 - 11:15 AM: Early-stage breast cancer- David Page, MD

11:15 - 11:45 AM: Metastatic breast cancer 1 (hormone receptor-positive)- Zheng Topp, MD

11:45 - 12:15 PM: Metastatic breast cancer 2 (HER2 +ve and triple-negative breast cancer)- Sasha Stanton, MD, PhD

DoubleTree by Hilton
1000 NE Multnomah St
Portland, OR 97232
United States

A limited number of rooms have been reserved at the DoubleTree by Hilton Hotel at the discounted daily rate of $169/night (single occupancy) for participants, vendors, and sponsors of this meeting. All reservations must be made by June 2, 2023, to receive the discounted rate. 

Book your rooms at the following link:

https://www.hilton.com/en/book/reservation/deeplink/?ctyhocn=RLLC-DT&groupCode=CDTASC&arrivaldate=2023-06-23&departuredate=2023-06-26&cid=OM,WW,HILTONLINK,EN,DirectLink&fromId=HILTONLINKDIRECT             

Travel

Parking:

  • Overnight parking with in & out privileges - $10/night
  • Daily parking rate for the participants of this conference - $10/day.
Course Director(s)

Julie Graff, MD

has no relevant financial relationships to disclose at this time.

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Prakash Ambady, MD

has no relevant financial relationships to disclose at this time.

Jeremy Cetnar

has no relevant financial relationships to disclose at this time.

Emerson Chen, MD

has no relevant financial relationships to disclose at this time.

Brendan Curti, Member, Earle A. Chiles Research Institute, Providence Cancer Institute

has a financial relationship (Grant Or Contract) with Iovance;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Professional Services) with Merck;.

Sudhir Isharwal, MD, FACS

has no relevant financial relationships to disclose at this time.

Peter Jiang

has no relevant financial relationships to disclose at this time.

Hyunseok Kang, MD, MPH

has a financial relationship (Independent contractor) with Bertis ;.
has a financial relationship (Independent contractor) with Coherus Biosciences;.
has a financial relationship (Independent contractor) with Pin Therapeutics;.
has a financial relationship (Independent contractor) with Cue Bio;.
has a financial relationship (Independent contractor) with LG Chem;.
has a financial relationship (Independent contractor) with Remix Therapeutics;.
has a financial relationship (Independent contractor) with Bayer;.

Adel Kardosh, MD, PhD

has a financial relationship (Other) with Astellas;.
has a financial relationship (Other) with Eisai;.
has a financial relationship (Other) with seagen;.
has a financial relationship (Grant Or Contract) with Natera;.
has a financial relationship (Other) with exelixis;.

Daneng Li

has a financial relationship (Grant Or Contract) with Brooklyn ImmunoTherapeutics;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with Servier;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Independent contractor) with Exelixis;.
has a financial relationship (Independent contractor) with QED;.
has a financial relationship (Independent contractor) with Eisai;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with TerSera Therapeutics;.
has a financial relationship (Independent contractor) with Adagene;.
has a financial relationship (Independent contractor) with Ipsen;.
has a financial relationship (Independent contractor) with Coherus;.

Eva Medvedova, MD

has no relevant financial relationships to disclose at this time.

Smitha Menon

has no relevant financial relationships to disclose at this time.

Craig Okada

has no relevant financial relationships to disclose at this time.

David Page, MD

has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with NGM Bio;.
has a financial relationship (Independent contractor) with Clinical Care Options;.
has a financial relationship (Grant Or Contract) with WindMIL;.
has a financial relationship (Independent contractor) with Oncocyte;.
has a financial relationship (Independent contractor) with Lilly;.
has a financial relationship (Independent contractor) with Astrazeneca/D-S;.
has a financial relationship (Grant Or Contract) with Brooklyn Immunotherapeutics;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with Sanford Burnham Presbys;.
has a financial relationship (Professional Services) with Biotheranostics;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Independent contractor) with Brooklyn Immunotherapeutics;.
has a financial relationship (Independent contractor) with Sanofi;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Independent contractor) with Novartis;.

Jennifer Saultz

has a financial relationship (Professional Services) with Rigel ;.
has a financial relationship (Grant Or Contract) with IKENA Oncology;.

Sasha Stanton, MD PhD

has a financial relationship (Grant Or Contract) with IMV Inc;.
has a financial relationship (Professional Services) with Stanford Prebys Burnham;.

Marshall Strother

has no relevant financial relationships to disclose at this time.

Zheng Topp, M.D.

has a financial relationship (Professional Services) with Astrazeneca;.

Cristian Valenzuela

has no relevant financial relationships to disclose at this time.

Dan Veljovich, MD

has a financial relationship (Stock) with VEEV Veeva Systems;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Stock) with ABBV Abbvie;.
has a financial relationship (Stock) with GILD GIlead;.
has a financial relationship (Stock) with JNJ Johnson and JOhnson;.
has a financial relationship (Stock) with PFE Pfizer;.
has a financial relationship (Independent contractor) with GSK;.
has a financial relationship (Stock) with ADPT Adaptive BIotech;.
has a financial relationship (Stock) with DOCS DOximity;.
has a financial relationship (Stock) with ISRG Intuitive surgical;.
has a financial relationship (Stock) with NVTA Invitae;.
has a financial relationship (Stock) with UNH United Health;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Stock) with CVS CVS Health;.
has a financial relationship (Stock) with HLN Haleon PLC;.
has a financial relationship (Stock) with MRNA Moderna;.
has a financial relationship (Stock) with TDOC Teladoc;.
has a financial relationship (Independent contractor) with Eisai;.
has a financial relationship (Stock) with AZN AstraZeneca;.
has a financial relationship (Stock) with GSK;.
has a financial relationship (Stock) with MRK Merck;.
has a financial relationship (Stock) with SGEN Seattle Genetics;.

Michael Wagner, M.D.

has a financial relationship (Independent contractor) with Epizyme;.
has a financial relationship (Independent contractor) with Deciphera;.
has a financial relationship (Independent contractor) with Adaptimmune;.

Bo Wang, Bo Wang, MD

has a financial relationship (Professional Services) with Guardant ;.
has a financial relationship (Professional Services) with EMD Sorono;.
has a financial relationship (Professional Services) with Astra Zeneca;.
has a financial relationship (Professional Services) with Sanofi Genzyme;.

Xiaowen Wang, MD, PhD

has no relevant financial relationships to disclose at this time.
Moderator(s)

Elizabeth Berry, MD

has a financial relationship (Grant Or Contract) with Bristol Myers Squibb;.

Andrew Coveler, MD

has a financial relationship (Independent contractor) with AbGenomics;.
has a financial relationship (Independent contractor) with Actuate;.
has a financial relationship (Independent contractor) with Astrazeneneca;.
has a financial relationship (Independent contractor) with Mirati;.
has a financial relationship (Travel) with Nucana;.
has a financial relationship (Independent contractor) with Amgen;.
has a financial relationship (Independent contractor) with Seagen;.

Curtis Lachowiez, M.D.

has no relevant financial relationships to disclose at this time.

Andrea Veatch, MD

has no relevant financial relationships to disclose at this time.

Fengting Yan, MD

has no relevant financial relationships to disclose at this time.
Planning committee(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

Commercial Support Acknowledgment

This activity is supported with an independent medical education grant from the following companies:

  • Novocure, Inc
  • Seagen.

Available Credit

  • 11.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 11.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 11.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.00 Contact Hours.

Price

Cost:
$350.00
Please login or register to take this course.

The early bird registration fee is effective until June 7, 2023. The registration fee will increase by $200 on June 8, 2023.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.